| AVP0127 | IINFYDPLVFPSDEFDASISQVNEKINQSLAFIRK | 35 | RSV | 91 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0128 | INFYDPLVFPSDEFDASISQVNEKINQSLAFIRKS | 35 | RSV | 93 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0129 | NFYDPLVFPSDEFDASISQVNEKINQSLAFIRKSD | 35 | RSV | >100 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0130 | FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDE | 35 | RSV | 20 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0131 | YDPLVFPSDEFDASISQVNEKINQSLAFIRKSDEL | 35 | RSV | 6 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0132 | DPLVFPSDEFDASISQVNEKINQSLAFIRKSDELL | 35 | RSV | 8 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0133 | PLVFPSDEFDASISQVNEKINQSLAFIRKSDELLH | 35 | RSV | 30 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0134 | LVFPSDEFDASISQVNEKINQSLAFIRKSDELLHN | 35 | RSV | 9 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0135 | VFPSDEFDASISQVNEKINQSLAFIRKSDELLHNV | 35 | RSV | 19 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0136 | FPSDEFDASISQVNEKINQSLAFIRKSDELLHNVN | 35 | RSV | 8 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0137 | PSDEFDASISQVNEKINQSLAFIRKSDELLHNVNA | 35 | RSV | 6 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0138 | SDEFDASISQVNEKINQSLAFIRKSDELLHNVNAG | 35 | RSV | 6 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0139 | DEFDASISQVNEKINQSLAFIRKSDELLHNVNAGK | 35 | RSV | 12 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0140 | EFDASISQVNEKINQSLAFIRKSDELLHNVNAGKS | 35 | RSV | 13 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0141 | FDASISQVNEKINQSLAFIRKSDELLHNVNAGKST | 35 | RSV | 6 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0142 | DASISQVNEKINQSLAFIRKSDELLHNVNAGKSTT | 35 | RSV | 8 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0143 | FDASISQVNEKINQSLAFIRKSDELLHNVNAGKST | 35 | RSV | 0.051 | EC50 (μM) | Fusion | Cytopathic effect | 8700906 |
| AVP0427 | ILMCFSIDSPDSLEN | 15 | RSV | 1.6 | μg/ml | Virus entry | Flow cytometry | 15113882 |
| AVP0428 | ILMAFSIDSPDSLEN | 15 | RSV | >100 | μg/ml | Virus entry | Flow cytometry | 15113882 |
| AVP0429 | ILMCFSINSPNSLQN | 15 | RSV | >100 | μg/ml | Virus entry | Flow cytometry | 15113882 |
| AVP1210 | ASLRVRIKK | 9 | RSV | 0.25 | μM | Virus entry | Plaque assay | 22850525 |
| AVP1310 | YTSVITIELSNIKENKCNGTDAKVKLIKQELDKYK | 35 | RSV | Medium | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1311 | TSVITIELSNIKENKCNGTDAKVKLIKQELDKYKN | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1312 | SVITIELSNIKENKCNGTDAKVKLIKQELDKYKNA | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1313 | VITIELSNIKENKCNGTDAKVKLIKQELDKYKNAV | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1314 | ITIELSNIKENKCNGTDAKVKLIKQELDKYKNAVT | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1315 | TIELSNIKENKCNGTDAKVKLIKQELDKYKNAVTE | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1316 | IELSNIKENKCNGTDAKVKLIKQELDKYKNAVTEL | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1317 | ELSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQ | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1318 | LSNIKENKCNGTDAKVKLIKQELDKYKNAVTELQL | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1319 | SNIKENKCNGTDAKVKLIKQELDKYKNAVTELQLL | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1320 | NIKENKCNGTDAKVKLIKQELDKYKNAVTELQLLM | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1321 | IKENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQ | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1322 | KENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQS | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1323 | ENKCNGTDAKVKLIKQELDKYKNAVTELQLLMQST | 35 | RSV | Nil | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1324 | IINFYDPLVFPSDEFDASISQVNEKINQSLAFIRK | 35 | RSV | Low | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1325 | INFYDPLVFPSDEFDASISQVNEKINQSLAFIRKS | 35 | RSV | Low | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1326 | NFYDPLVFPSDEFDASISQVNEKINQSLAFIRKSD | 35 | RSV | Low | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1327 | FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDE | 35 | RSV | Medium | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1328 | YDPLVFPSDEFDASISQVNEKINQSLAFIRKSDEL | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1329 | DPLVFPSDEFDASISQVNEKINQSLAFIRKSDELL | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1330 | PLVFPSDEFDASISQVNEKINQSLAFIRKSDELLH | 35 | RSV | Medium | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1331 | LVFPSDEFDASISQVNEKINQSLAFIRKSDELLHN | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1332 | VFPSDEFDASISQVNEKINQSLAFIRKSDELLHNV | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1333 | FPSDEFDASISQVNEKINQSLAFIRKSDELLHNVN | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1334 | PSDEFDASISQVNEKINQSLAFIRKSDELLHNVNA | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1335 | SDEFDASISQVNEKINQSLAFIRKSDELLHNVNAG | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1336 | DEFDASISQVNEKINQSLAFIRKSDELLHNVNAGK | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1337 | EFDASISQVNEKINQSLAFIRKSDELLHNVNAGKS | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1338 | FDASISQVNEKINQSLAFIRKSDELLHNVNAGKSI | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1339 | DASISQVNEKINQSLAFIRKSDELLHNVNAGKSIT | 35 | RSV | High | - | Fusion | Immunoprecipitation | US6440656 |
| AVP1413 | VAVSKVLHLEGEVNKIALLSTNKAVVSLSNGVS | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1414 | AVSKVLHLEGEVNKIALLSTNKAVVSLSNGVSV | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1415 | VSKVLHLEGEVNKIALLSTNKAVVSLSNGVSVL | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1416 | SKVLHLEGEVNKIALLSTNKAVVSLSNGVSVLT | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1417 | KVLHLEGEVNKIALLSTNKAVVSLSNGVSVLTS | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1418 | LEGEVNKIALLSTNKAVVSLSNGVSVLTSKVLD | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1419 | GEVNKIALLSTNKAVVSLSNGVSVLTSKVLDLK | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1420 | EVNKIALLSTNKAVVSLSNGVSVLTSKVLDLKN | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1421 | VNKIALLSTNKAVVSLSNGVSVLTSKVLDLKNY | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1422 | NKIALLSTNKAVVSLSNGVSVLTSKVLDLKNYI | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1423 | KIALLSTNKAVVSLSNGVSVLTSKVLDLKNYID | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1424 | IALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDK | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1425 | ALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQ | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1426 | VAVSKVLHLEGEVNKIALLSTNKAVVSLSNGVS | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1427 | AVSKVLHLEGEVNKIALLSTNKAVVSLSNGVSV | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1428 | VSKVLHLEGEVNKIALLSTNKAVVSLSNGVSVL | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1429 | SKVLHLEGEVNKIALLSTNKAVVSLSNGVSVLT | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1430 | KVLHLEGEVNKIALLSTNKAVVSLSNGVSVLTS | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1431 | LEGEVNKIALLSTNKAVVSLSNGVSVLTSKVLD | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1432 | GEVNKIALLSTNKAVVSLSNGVSVLTSKVLDLK | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1433 | EVNKIALLSTNKAVVSLSNGVSVLTSKVLDLKN | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1434 | VNKIALLSTNKAVVSLSNGVSVLTSKVLDLKNY | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1435 | NKIALLSTNKAVVSLSNGVSVLTSKVLDLKNYI | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1436 | KIALLSTNKAVVSLSNGVSVLTSKVLDLKNYID | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1437 | IALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDK | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1438 | ALLSTNKAVVSLSNGVSVLTSKVLDLKNYIDKQ | 33 | RSV | High | - | Major surface glycoprotein G | Cell-fusion assay | US6951717 |
| AVP1534 | YQSTCSAVSKGYLSALR | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1535 | TSVITIELSNIKKIKCN | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1536 | LSNIKKIKCNGTDAKVK | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1537 | NNAKKTNVTLSKKRKRR | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1538 | KTNVTLSKKRKRRFLGF | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1539 | KKRKRRFLGFLLGVGSA | 17 | RSV | High | - | Virus entry | Flow cytometry | 17050595 |
| AVP1540 | KQLLPIVNKQSCSISNI | 17 | RSV | Low | - | Virus entry | Flow cytometry | 17050595 |
| AVP1541 | LLSLINDMPITNDQKKL | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1542 | MPITNDQKKLMSNNVQI | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1543 | KKLMSNNVQIVRQQSYS | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1544 | KEGSNICLTRTDRGWYC | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1545 | SSVITSLGAIVSCYGKT | 17 | RSV | High | - | Virus entry | Flow cytometry | 17050595 |
| AVP1546 | GKTKCTASNKNRGIIKT | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1547 | IIIVIIVILLSLIAVGL | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1548 | VGLLLYCKARSTPVTLS | 17 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1549 | AICKRIPNKKPGKKT | 15 | RSV | Medium | - | Virus entry | Flow cytometry | 17050595 |
| AVP1550 | NPTCWAICKRIPNKK | 15 | RSV | Medium | - | Virus entry | Flow cytometry | 17050595 |
| AVP1551 | ENREILKEPVHGVYY | 15 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1552 | AKKQRFRHRNRKG | 13 | RSV | Nil | - | Virus entry | Flow cytometry | 17050595 |
| AVP1581 | YDPLVFPSDEFDASISQVNEKINQSLAFIRKSDELLHNV | 39 | RSV | High | - | Virus entry | Syncitia assay | 20534864 |
| AVP1924 | TDVILMCFSIDSPDSLENI | 19 | RSV | 7.6 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1925 | CSIELSDIPLSVDFNTMID | 19 | RSV | >50 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1926 | ADVILMCFSIDSPDSLENI | 19 | RSV | 2.56 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1927 | TAVILMCFSIDSPDSLENI | 19 | RSV | 1.37 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1928 | TDAILMCFSIDSPDSLENI | 19 | RSV | 6.6 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1929 | TDVALMCFSIDSPDSLENI | 19 | RSV | 11.6 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1930 | TDVIAMCFSIDSPDSLENI | 19 | RSV | 5.42 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1931 | TDVILACFSIDSPDSLENI | 19 | RSV | 1.43 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1932 | TDVILMAFSIDSPDSLENI | 19 | RSV | >50 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1933 | TDVILMCASIDSPDSLENI | 19 | RSV | 6.29 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1934 | TDVILMCFAIDSPDSLENI | 19 | RSV | 6.82 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1935 | TDVILMCFSADSPDSLENI | 19 | RSV | 3.52 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1936 | TDVILMCFSIASPDSLENI | 19 | RSV | 4.36 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1937 | TDVILMCFSIDAPDSLENI | 19 | RSV | 2.26 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1938 | TDVILMCFSIDSADSLENI | 19 | RSV | 15.32 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1939 | TDVILMCFSIDSPASLENI | 19 | RSV | 2.61 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1940 | TDVILMCFSIDSPDALENI | 19 | RSV | 1.19 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1941 | TDVILMCFSIDSPDSAENI | 19 | RSV | 2.27 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1942 | TDVILMCFSIDSPDSLANI | 19 | RSV | 9.83 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1943 | TDVILMCFSIDSPDSLEAI | 19 | RSV | 18.47 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1944 | TDVILMCFSIDSPDSLENA | 19 | RSV | 4.89 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1945 | TDVILMCFSI | 10 | RSV | >50 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1946 | TDVILMCFSIDSP | 13 | RSV | >50 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1947 | TDVILMCFSIDSPDSL | 16 | RSV | 10.86 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1948 | DVILMCFSIDSPDSLENI | 18 | RSV | 1.23 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1949 | VILMCFSIDSPDSLENI | 17 | RSV | 16.95 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1950 | ILMCFSIDSPDSLENI | 16 | RSV | 7.17 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1951 | CFSIDSPDSLENI | 13 | RSV | >50 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1952 | ILMCFSIDSPDSLEN | 15 | RSV | 1.75 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1953 | ILMCFSIDSPDSLE | 14 | RSV | 3.5 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1954 | ILMCFSIDSPDSL | 13 | RSV | 12.4 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1955 | ILMCFSIDSPDS | 12 | RSV | 6.36 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1956 | ILMCFSIDSPD | 11 | RSV | 4.61 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1957 | ILMCFSIDSP | 10 | RSV | 35.77 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1958 | ILMCFSIDS | 9 | RSV | >50 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1959 | ILMCFSID | 8 | RSV | >50 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1960 | ILMCFSI | 7 | RSV | >50 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1961 | ILMCFS | 6 | RSV | >50 | μM | Replication | Viral antigen reduction assay | 14576104 |
| AVP1971 | AVSKVLHLEGEVNKISALLSTNKAVVSLSNGVSVLTSKVLDLDNYIDKQLLPIVNK | 56 | RSV | 1.68 | μM | Fusion | Cell-fusion assay | 12615056 |
| AVP1972 | NFYDPLVFPSDEFDASISQVNEKINQSLASIRKSDELLHNVNAGK | 45 | RSV | 2.93 | μM | Fusion | Cell-fusion assay | 12615056 |
| AVP2000 | KQRQNKPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKK | 49 | RSV | 80 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2001 | FHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKK | 35 | RSV | 80 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2002 | VPCSICSNNPTCWAICKRIPNKKPGKK | 27 | RSV | >165 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2003 | CSICSNNPTCWAICKRIPNKKPGKK | 25 | RSV | >177 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2004 | KQRQNKPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRI | 41 | RSV | 12 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2005 | KPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRI | 36 | RSV | 12 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2006 | KPNNDFHFEVFNFVPCSICSNNPTCWAICKRI | 32 | RSV | 25 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2007 | KQRQNKPPSKPNNDFHFEVFN | 21 | RSV | >190 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2008 | KQRQNKPPSKPNNDFHF | 17 | RSV | >240 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2009 | KPPSKPNNDFHFEVFNFVP | 19 | RSV | 220 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2010 | KPPSKPNNDFHFEVFNFV | 18 | RSV | 14 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2011 | KPPSKPNNDFHFEVFNF | 17 | RSV | 7 | μM | Cytopathic effect | NMR | 11487583 |
| AVP2012 | KPPSKPNNDFHFEVFN | 16 | RSV | >510 | μM | Cytopathic effect | NMR | 11487583 |
